Pacira BioSciences
PCRX
PCRX
238 hedge funds and large institutions have $768M invested in Pacira BioSciences in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 88 closing their positions.
Holders
238
Holders Change
-42
Holders Change %
-15%
% of All Funds
3.44%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.01%
New
47
Increased
86
Reduced
69
Closed
88
Calls
$6.72M
Puts
$5.74M
Net Calls
+$979K
Net Calls Change
+$29.5M
Top Buyers
1 |
1
Pacer Advisors
Malvern,
Pennsylvania
|
$74.7M |
2 |
2
D.E. Shaw & Co
New York
|
$29.5M |
3 |
3
Arrowstreet Capital
Boston,
Massachusetts
|
$17.3M |
4 |
4
Morgan Stanley
New York
|
$24M |
5 |
DPCM
5
Doma Perpetual Capital Management
Miami,
Florida
|
$26.3M |